Location, Spreading and Oral Corticosteroids are Associated with Insomnia in Vitiligo Patients: A Case–Control Study

References

• Buysse DJ. Insomnia. JAMA. 2013;309:706–716. doi:10.1001/jama.2013.193
   PubMed Web of Science ®Google Scholar
• Wilson S, Anderson K, Baldwin D, et al. British association for psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. J Psychopharmacol. 2019;33:923–947. doi:10.1177/0269881119855343
   PubMed Web of Science ®Google Scholar
• Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386:74–84. doi:10.1016/S0140-6736(14)60763-7
   PubMed Web of Science ®Google Scholar
• Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017;77:1–13. doi:10.1016/j.jaad.2016.10.048
   PubMed Web of Science ®Google Scholar
• Elbuluk N, Ezzedine K. Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients. Dermatol Clin. 2017;35:117–128. doi:10.1016/j.det.2016.11.002
   PubMed Web of Science ®Google Scholar
• Simons RE, Zevy DL, Jafferany M. Psychodermatology of vitiligo: psychological impact and consequences. Dermatol Ther. 2020;33:e13418. doi:10.1111/dth.13418
   PubMed Web of Science ®Google Scholar
• Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol. 2001;28:419–423. doi:10.1111/j.1346-8138.2001.tb00003.x
   PubMed Web of Science ®Google Scholar
• Hsiao YH, Chen YT, Tseng CM, et al. Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea. Sleep. 2015;38:581–586. doi:10.5665/sleep.4574
   Web of Science ®Google Scholar
• Seo HM, Kim TL, Kim JS. The risk of alopecia areata and other related autoimmune diseases in patients with sleep disorders: a Korean population-based retrospective cohort study. Sleep. 2018;41:1–8. doi:10.1093/sleep/zsy111
   Web of Science ®Google Scholar
• Njoo MD, Das PK, Bos JD, Westerhof W. Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999;135:407–413. doi:10.1001/archderm.135.4.407
   PubMedGoogle Scholar
• Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140:677–683. doi:10.1001/archderm.140.6.677
   PubMed Web of Science ®Google Scholar
• Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34:601–608. doi:10.1093/sleep/34.5.601
   PubMed Web of Science ®Google Scholar
• Thorpy MJ. Classification of sleep disorders. Neurotherapeutics. 2012;9:687–701. doi:10.1007/s13311-012-0145-6
   PubMed Web of Science ®Google Scholar
• Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: a systematic review. Sleep Med Rev. 2016;29:63–75. doi:10.1016/j.smrv.2015.09.003
   PubMed Web of Science ®Google Scholar
• Reszke R, Szepietowski JC. End-stage renal disease chronic itch and its management. Dermatol Clin. 2018;36:277–292. doi:10.1016/j.det.2018.02.007
   Web of Science ®Google Scholar
• Bender BG, Ballard R, Canono B, Murphy JR, Leung DY. Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol. 2008;58:415–420. doi:10.1016/j.jaad.2007.10.010
   PubMed Web of Science ®Google Scholar
• Kaaz K, Szepietowski JC, Matusiak Ł. Influence of itch and pain on sleep quality in atopic dermatitis and psoriasis. Acta Derm Venereol. 2019;99:175–180. doi:10.2340/00015555-3065
   Web of Science ®Google Scholar
• Bender BG, Leung DY. Sleep disorders in patients with asthma, atopic dermatitis, and allergic rhinitis. J Allergy Clin Immunol. 2005;116:1200–1201. doi:10.1016/j.jaci.2005.09.041
   Web of Science ®Google Scholar
• Hamidizadeh N, Ranjbar S, Ghanizadeh A, Parvizi MM, Jafari P, Handjani F. Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population. Health Qual Life Outcomes. 2020;18:20. doi:10.1186/s12955-020-1278-7
   PubMed Web of Science ®Google Scholar
• Mouzas O, Angelopoulos N, Papaliagka M, Tsogas P. Increased frequency of self-reported parasomnias in patients suffering from vitiligo. Eur J Dermatol. 2008;18:165–168.
   Web of Science ®Google Scholar
• Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med. 2003;4:343–345. doi:10.1016/S1389-9457(03)00059-5
   PubMed Web of Science ®Google Scholar
• Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177:708–718. doi:10.1111/bjd.15199
   PubMed Web of Science ®Google Scholar
• Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis. J Eur Acad Dermatol Venereol. 2018;32:1343–1351. doi:10.1111/jdv.14739
   Web of Science ®Google Scholar
• Silpa-Archa N, Pruksaeakanan C, Angkoolpakdeekul N, et al. Relationship between depression and quality of life among vitiligo patients: a self-assessment questionnaire-based study. Clin Cosmet Investig Dermatol. 2020;13:511–520. doi:10.2147/CCID.S265349
   PubMed Web of Science ®Google Scholar
• Leistedt S, Kempenaers C, Linkowski P. Neurophysiological and clinical aspects of psychophysiological insomnia. Rev Med Brux. 2007;28:11–20.
   Google Scholar
• Perlis ML, Giles DE, Mendelson WB, Bootzin RR, Wyatt JK. Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res. 1997;6:179–188. doi:10.1046/j.1365-2869.1997.00045.x
   PubMed Web of Science ®Google Scholar
• Moreno CRC, Santos JLF, Lebrão ML, Ulhôa MA, Duarte YAO. Sleep disturbances in older adults are associated to female sex, pain and urinary incontinence. Rev Bras Epidemiol. 2019;21(Suppl 02):e180018. doi:10.1590/1980-549720180018.supl.2
   Google Scholar
• Sidani S, Guruge S, Fox M, Collins L. Gender differences in perpetuating factors, experience and management of chronic insomnia. J Gend Stud. 2019;28:402–413. doi:10.1080/09589236.2018.1491394
   Web of Science ®Google Scholar
• Koehl M, Battle SE, Turek FW. Sleep in female mice: a strain comparison across the estrous cycle. Sleep. 2003;26:267–272. doi:10.1093/sleep/26.3.267
   PubMed Web of Science ®Google Scholar
• Nam GE, Han K, Lee G. Association between sleep duration and menstrual cycle irregularity in Korean female adolescents. Sleep Med. 2017;35:62–66. doi:10.1016/j.sleep.2017.04.009
   PubMed Web of Science ®Google Scholar
• Luca G, Haba Rubio J, Andries D, et al. Age and gender variations of sleep in subjects without sleep disorders. Ann Med. 2015;47:482–491. doi:10.3109/07853890.2015.1074271
   PubMed Web of Science ®Google Scholar
• Åkerstedt T, Ghilotti F, Grotta A, Bellavia A, Lagerros YT, Bellocco R. Sleep duration, mortality and the influence of age. Eur J Epidemiol. 2017;32:881–891. doi:10.1007/s10654-017-0297-0
   Web of Science ®Google Scholar
• Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1:73–77. doi:10.1016/0163-8343(79)90081-1
   PubMed Web of Science ®Google Scholar
• Porter J, Beuf AH, Lerner A, Nordlund J. Response to cosmetic disfigurement: patients with vitiligo. Cutis. 1987;39:493–494.
   PubMed Web of Science ®Google Scholar
• Porter JR, Beuf AH, Lerner AB, Nordlund JJ. The effect of vitiligo on sexual relationships. J Am Acad Dermatol. 1990;22:221–222. doi:10.1016/0190-9622(90)70028-G
   PubMed Web of Science ®Google Scholar
• Pahwa P, Mehta M, Khaitan BK, Sharma VK, Ramam M. The psychosocial impact of vitiligo in Indian patients. Indian J Dermatol Venereol Leprol. 2013;79:679–685. doi:10.4103/0378-6323.116737
   PubMed Web of Science ®Google Scholar
• Fehm HL, Benkowitsch R, Kern W, Fehm-Wolfsdorf G, Pauschinger P, Born J. Influences of corticosteroids, dexamethasone and hydrocortisone on sleep in humans. Neuropsychobiology. 1986;16:198–204. doi:10.1159/000118326
   Web of Science ®Google Scholar
• Holsboer F, Wiedemann K, Rupprecht R, Steiger A. Effects of corticosteroids and neurosteroids on sleep EEG. Clin Neuropharmacol. 1992;15(Pt A):588a–589a. doi:10.1097/00002826-199201001-00305
   Google Scholar
• Pasricha JS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol. 1993;32:753. doi:10.1111/j.1365-4362.1993.tb02754.x
   PubMed Web of Science ®Google Scholar
• Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol. 1999;72(Pt 3):385–396. doi:10.1348/000711299160077
   Web of Science ®Google Scholar